Janus Henderson Group PLC Fulcrum Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $53,690 - $265,418	18,972 New	18,972 $54,000
Q1 2021 May 17, 2021	SELL	$10.94 - $15.32 $2.51 Million - $3.52 Million	-229,634 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.84 - $13.4 $411,349 - $703,071	52,468 Added 29.62%	229,634 $2.69 Million
Q3 2020 Nov 16, 2020	BUY	$7.22 - $20.7 $1.28 Million - $3.67 Million	177,166 New	177,166 $1.4 Million

134

52.8M

3.08M

316K

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $192M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.